(redirected from Procardia xl)
Also found in: Dictionary, Medical.
Related to Procardia xl: Calcium channel blockers, Nifedical XL
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for nifedipine

calcium blocker (trade name Procardia)

References in periodicals archive ?
This is the generic version of Pfizer's Procardia XL Tablets, a treatment for angina and/or hypertension.
Seven (7.6%) participants correctly identified all medications whose unit cost was $1.51 or more (Cipro, Prozac, Suprax, Axid, Procardia XL, PediaProfen, and Feldene) (Figure 1).
Biovail Corporation (NYSE:BVF)(TSE:BVF), Toronto, has announced that its 30mg dosage strength of generic Procardia XL (once daily nifedipine) has been granted final approval by the Food and Drug Administration (FDA) for immediate marketing in the United States.
Nifedipine is the generic version of Procardia XL for the treatment of hypertension and angina; etodolac is the generic version of Lodine XL, indicated for managing signs and symptoms of osteoarthritis and rheumatoid arthritis.
For example, Teva Pharmaceuticals USA recently filed a citizen petition before the FDA asserting that Mylan Laboratories Inc.'s 180 days of exclusivity for its generic nifedipinse should be suspended, because Mylan has settled patent litigation with Pfizer Inc., which makes the extended-release tablets under the Procardia XL brand name.
will lose patent protection on Procardia XL. which generates sales of more than $1 billion; Eli Lilly and Co.
Other highlights, according to a company spokeswoman, are a strategic alliance, a filing for a generic alternative to Procardia XL and Mylan's exclusive ranitidine (Zantac) agreement with Genpharm Inc.
The system has been designed to emulate the performance of the osmotic pump system used with such products as Procardia XL, a spokesman says.
Pfizer Inc., also rated a hold, is recording strong sales gains from Zithromax, Zoloft, Norvasc and Cardura, which should more than offset an anticipated decline in Procardia XL sales.
They point out that the study doesn't involve Pfizer's long-acting CCBs Norvasc and Procardia XL.
Relatively new products that are selling well include: Procardia XL, a cardiovascular medication; Diflucan, an antifungal for AIDS victims; Zoloft, for depression; and Zithromax, an antibiotic.